Skip to main content
OpenTrials
Completed

NCT Number: NCT00813397

Manageability and Safety Assessment of Sepraspray in Abdominal Surgery.

This study will examine the performance of SeprasSpray in patients undergoing abdominal surgery (laparoscopic).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Adhesion Prevention

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU Amiens Nord, Amiens, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients 18 years old and over that require laparoscopic abdominal surgery

Exclusion criteria

  • Patients who are pregnant or have an ongoing infectious complications from a previous surgery

Treatment and study plan

Sepraspray

Device

Max. 10g of Sepraspray

Primary outcomes

  1. Morbidity

    Time frame: 30 days

Sponsors and collaborators

Lead sponsor

Genzyme, a Sanofi Company

Industry

Registry information

Official study title

Manageability and Safety Assessment of the SepraSpray Anti-adhesion Barrier in Abdominal Coelioscopic Surgery

Acronym: C-MUST

Important dates

Study start
2008
Primary completion
2009
Study completion
2009
First posted
Dec 23, 2008
Registry last updated
May 22, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.